Paper Details

  1. Home
  2. Paper Details

Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review.

Author: AkagiKie, FuruieHiroki, KawashimaTomoko, KawashimaYoshitaka, KuniishiHiroshi, NodaTakamasa, YamadaMisa, YamadaMitsuhiko

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study aims to evaluate the efficacy and tolerability of riluzole for patients with anxiety or fear as primary symptoms.
Paper Details　
Original Abstract of the Article :
Previous behavioral pharmacology studies involving rodents suggested riluzole had potential to be an ideal psychotropic drug for psychiatric disorders with anxiety or fear as primary symptoms. Several clinical studies have recently been conducted. The purpose of this study was to gather information ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496048/

データ提供：米国国立医学図書館（NLM）

Riluzole for Psychiatric Disorders: A New Frontier in the Desert of Mental Health

Riluzole, a medication primarily used to treat amyotrophic lateral sclerosis (ALS), has shown promise in treating psychiatric disorders with anxiety or fear as primary symptoms. This systematic review examines the clinical studies exploring riluzole's efficacy and tolerability for patients with these symptoms. Researchers sought to synthesize the available evidence, providing insights into riluzole's potential as a novel treatment option for anxiety and fear-related disorders.

Riluzole's Potential: A New Oasis in the Desert of Anxiety

The review found that several clinical studies have investigated riluzole's effects on anxiety and fear-related disorders, with some suggesting potential benefits. However, the evidence base remains limited, and further research is needed to establish riluzole's efficacy and optimal dosing strategies for these conditions. The review also highlights the need to consider the potential for side effects and interactions with other medications when evaluating riluzole's use for psychiatric disorders.

Navigating the Desert of Mental Health: Exploring New Horizons

This review underscores the importance of exploring novel treatment options for anxiety and fear-related disorders. While riluzole shows promise, further research is crucial to solidify its efficacy and safety profile. As we navigate the vast desert of mental health, embracing new horizons and exploring innovative treatments can lead to more effective and compassionate care for those struggling with these conditions.

Dr.Camel's Conclusion

This review suggests that riluzole may have potential for treating psychiatric disorders with anxiety or fear as primary symptoms, but further research is needed to confirm its efficacy and safety. The exploration of new treatment options like riluzole reflects our ongoing commitment to improving the lives of those struggling with mental health challenges.

Date :
  1. Date Completed 2023-09-13
  2. Date Revised 2023-10-03
Further Info :

Pubmed ID

37463744

DOI: Digital Object Identifier

PMC10496048

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.